journal article·2023-06-27Open access

Revealing Population Heterogeneity in Vesicle-Based Nanomedicines Using Automated, Single Particle Raman Analysis

Catherine Saunders, James E. J. Foote, Jonathan P. Wojciechowski, Ana Cammack, Simon V. Pedersen, James J. Doutch, Hanna M. G. Barriga, Margaret N. Holme, Jelle Penders, Mohamed Chami, Adrian Najer, Molly M. Stevens

ACS Nano· Volume 17· Issue 12

Abstract

The intrinsic heterogeneity of many nanoformulations is currently challenging to characterize on both the single particle and population level. Therefore, there is great opportunity to develop advanced techniques to describe and understand nanomedicine heterogeneity, which will aid translation to the clinic by informing manufacturing quality control, characterization for regulatory bodies, and connecting nanoformulation properties to clinical outcomes to enable rational design. Here, we present an analytical technique to provide such information, while measuring the nanocarrier and cargo simultaneously with label-free, nondestructive single particle automated Raman trapping analysis (SPARTA). We first synthesized a library of model compounds covering a range of hydrophilicities and providing distinct Raman signals. These compounds were then loaded into model nanovesicles (polymersomes) that can load both hydrophobic and hydrophilic cargo into the membrane or core regions, respectively. Using our analytical framework, we characterized the heterogeneity of the population by correlating the signal per particle from the membrane and cargo. We found that core and membrane loading can be distinguished, and we detected subpopulations of highly loaded particles in certain cases. We then confirmed the suitability of our technique in liposomes, another nanovesicle class, including the commercial formulation Doxil. Our label-free analytical technique precisely determines cargo location alongside loading and release heterogeneity in nanomedicines, which could be instrumental for future quality control, regulatory body protocols, and development of structure-function relationships to bring more nanomedicines to the clinic.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Spectroscopy Techniques in Biomedical and Chemical Research · Gold and Silver Nanoparticles Synthesis and Applications · Protein Interaction Studies and Fluorescence Analysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Materials, Department of Bioengineering, and Institute of Biomedical Engineering, Imperial College London, London SW7 2AZ, United Kingdom

ISIS Neutron and Muon Source, Rutherford Appleton Laboratory, Science and Technology Facilities Council, Didcot OX11 ODE, United Kingdom

Department of Medical Biochemistry and Biophysics, Karolinska Institutet, SE-171 77 Stockholm, Sweden

BioEM Lab, Biozentrum, University of Basel, Mattenstrasse 26, 4058 Basel, Switzerland

Funding

Engineering and Physical Sciences Research Council · Royal Academy of Engineering · Schweizerischer Nationalfonds zur F?rderung der Wissenschaftlichen Forschung · Norges Forskningsr?d · Danmarks Frie Forskningsfond · Wellcome Trust · H2020 Marie Sklodowska-Curie Actions · Rosetrees Trust · UK Regenerative Medicine Platform

References (55)

Show source-provided references
1. 10.3389/fchem.2018.0036010.3389/fchem.2018.00360 ↗
2. 10.1038/nrc.2016.10810.1038/nrc.2016.108 ↗
3. 10.1016/j.jddst.2022.10387810.1016/j.jddst.2022.103878 ↗
4. 10.1038/s41571-022-00699-x10.1038/s41571-022-00699-x ↗
5. 10.1088/1361-6528/ac85f310.1088/1361-6528/ac85f3 ↗
6. 10.1002/(SICI)1097-4636(19980305)39:3<478::AID-JBM19>3.0.CO;2-610.1002/(SICI)1097-4636(19980305)39:3<478::AID-JBM19>3.0.CO;2-6 ↗
7. Immordino M. L. · Int. J. Nanomedicine · 2006 · 1 · 29710.2217/17435889.1.3.297 ↗
8. 10.1007/s40089-017-0221-310.1007/s40089-017-0221-3 ↗
9. 10.1016/j.fmre.2022.09.01110.1016/j.fmre.2022.09.011 ↗
10. 10.1016/j.addr.2018.06.02410.1016/j.addr.2018.06.024 ↗
11. Food and Drug Administration; Center for Drug Evaluation and Research; Center for Biologics Evaluation and Research. Drug Products, Including Biological Products, That Contain Nanomaterials Guidance for Industry, FDA-2017-D-0759, last revised April 2022. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/drug-products-including-biological-products-contain-nanomaterials-guidance-industry (accessed 2023-05-22).
12. 10.1002/btm2.1014310.1002/btm2.10143 ↗
13. 10.3390/molecules2704137210.3390/molecules27041372 ↗
14. 10.1039/C9MH01669D10.1039/C9MH01669D ↗
15. 10.1126/science.107497210.1126/science.1074972 ↗
16. 10.1021/acsomega.8b0231110.1021/acsomega.8b02311 ↗
17. 10.1016/j.jconrel.2006.07.01210.1016/j.jconrel.2006.07.012 ↗
18. 10.1021/ar200036k10.1021/ar200036k ↗
19. 10.1016/j.jconrel.2009.11.01210.1016/j.jconrel.2009.11.012 ↗
20. 10.1021/acsami.6b0584710.1021/acsami.6b05847 ↗
21. 10.1038/s41467-018-07755-010.1038/s41467-018-07755-0 ↗
22. 10.1021/acsnano.1c0486210.1021/acsnano.1c04862 ↗
23. 10.1002/adma.20220083910.1002/adma.202200839 ↗
24. 10.1016/S0006-3495(03)74927-310.1016/S0006-3495(03)74927-3 ↗
25. 10.1002/jrs.248310.1002/jrs.2483 ↗
26. 10.1021/ac060529010.1021/ac0605290 ↗
27. 10.1038/s41467-018-06397-610.1038/s41467-018-06397-6 ↗
28. 10.1002/smll.20220199310.1002/smll.202201993 ↗
29. 10.1021/acscentsci.1c0136810.1021/acscentsci.1c01368 ↗
30. 10.1021/acsnano.0c0745910.1021/acsnano.0c07459 ↗
31. 10.1038/nmeth.457810.1038/nmeth.4578 ↗
32. 10.1038/s41467-019-13784-010.1038/s41467-019-13784-0 ↗
33. 10.1021/acs.analchem.9b0283810.1021/acs.analchem.9b02838 ↗
34. 10.1021/ja308529n10.1021/ja308529n ↗
35. 10.1021/acs.joc.1c0219410.1021/acs.joc.1c02194 ↗
36. 10.1021/acsomega.8b0341010.1021/acsomega.8b03410 ↗
37. 10.1039/C7OB02196H10.1039/C7OB02196H ↗
38. 10.1002/anie.20211407010.1002/anie.202114070 ↗
39. 10.1021/la990951u10.1021/la990951u ↗
40. 10.1021/acs.biomac.9b0141610.1021/acs.biomac.9b01416 ↗
41. 10.1039/C5CS00569H10.1039/C5CS00569H ↗
42. 10.1039/b604212k10.1039/b604212k ↗
43. 10.1016/j.molstruc.2010.03.05410.1016/j.molstruc.2010.03.054 ↗
44. 10.1021/acsnano.1c0707510.1021/acsnano.1c07075 ↗
45. 10.1038/s41596-020-0322-810.1038/s41596-020-0322-8 ↗
46. Brunet J.-P. · Proc. Natl. Acad. Sci. U.S.A · 2004 · 101 · 416410.1073/pnas.0308531101 ↗
47. 10.1080/0570492070155153010.1080/05704920701551530 ↗
48. 10.1039/C8AY01413B10.1039/C8AY01413B ↗
49. 10.1016/j.jconrel.2015.05.28410.1016/j.jconrel.2015.05.284 ↗
50. 10.1021/jp065136j10.1021/jp065136j ↗
51. 10.1016/j.nano.2015.06.00710.1016/j.nano.2015.06.007 ↗
52. 10.3109/03639045.2014.95458210.3109/03639045.2014.954582 ↗
53. 10.1016/j.nima.2014.07.02910.1016/j.nima.2014.07.029 ↗
54. 10.1002/adfm.20190426710.1002/adfm.201904267 ↗
55. 10.5286/ISIS.E.RB201045210.5286/ISIS.E.RB2010452 ↗